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ABSTRACT 
This review considers casual inference in observational studies which can prove medical treatment. The main aim of this study is to describe 
about its application in non-randomized clinical studies and in persons who support regulatory applications for marketing medical product. 
Propensity score makes an easy study about the large number of groups which cannot be randomized. By measuring the covariates, the 
methods which are used to measure the propensity score mimic the covariates. This study shows an illustration of the steps in the study and 
construction of propensity scores verses normal treatment of seriously ill individuals. Propensity score has the major advantage over alternate 
approaches when the treatment methods of illness do not overlap. 
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Introduction:- 
Propensity score analysis was first introduced by 
Rosenbaum and Rubin.(1).mPropensity score e(x) for the 
subject with vector(x) of observed covariates is probability 
of receiving treatment (z=1) rather than control(z=0) 
e(x)=pr(z=1)x 
Propensity score analysis is a versatile statistical method for 
the casual inference in observational studies which can 
prove treatment. In recent years interest in applying this 
methodology to the following 
(1)Non randomized clinical studies. 
 (2)Persons those who support regulatory applications for 
marketing medical products. 
Propensity score helps in separating groups on a large 
number of covariates measured at  a baseline. This process is 
helpful when participants cannot be randomized to treating 
conditions. At that time propensity score helps in equating 
the groups to match the other similar group. Various process 
used are matching, stratification, weighting or analysis of 
covariates procedure. According to this procedure the 
researches can differentiate treatment[t] and controlled[c] 
groups at baseline on a large number. 
 
Propensity Score:- 
Propensity score is balancing score in the sense that it is the 
function of observed covariates(x) such that the conditional 
distribution of x given e(x) is the same for the subjects in 
treatment group and also subjects in the control group. If 
treatments assigned are ignorable, that is the treatment 
assignment(Z) and potential outline(Y) are conditionally 
independent in the given covariates(X) 
i.e Pr(Z (X,Y)=Pr(Z(X) And if 0<Pr e(X)<1 
for all X, then the average effect at each value of propensity 
score is unbiased estimate of true treatment effect at 
propensity score(1).The above assumption requires that all 
covariates relevant to both treatment assignment and 
potential outcomes are measured(no hidden bias). In 
practice the propensity score is estimated by modeling the 
probability of treatment group. 
  Eg;-Multiple logistic Regression/ discriminant analysis. 
Propensity score matching, stratification, weighting, 
covariate adjustment and their combinations are used to 
produce unbiased estimate of treatment effect.(1-3) 
Propensity score is one dimensional summary of observed 
covariates such that propensity scores are balanced scores 
of two treatment groups, the distribution of all covariates 
balanced across two groups. Therefore, evaluating treatment 
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group overlap in terms of distribution of propensity scores 
that provides straight Forward Assessment of whether the 
two treatment groups are similar to baseline covariates. 
When overlap is present the propensity score analysis 
provides straight forward treatment. According to Rubin, the 
propensity score, prediction model should be reformulated 
or should conclude that covariate distribution should not 
overlap prosperity score analysis. 
Regulatory Setting:- 
In Regulatory environment, it is crucial to start with 
comparison with patient population because propensity 
score analysis did not work well. When there is a serious 
imbalance in baseline covariates between two treatment 
groups unfortunately, it is sometimes impossible to predict 
in advance whether patient population with new treatment 
is comparable to that of control, which is risk to take into 
consideration. Unsuccessful non randomized is somewhat 
burdensome than randomized trial or study (4,5).Like other 
covariate adjustment methods, propensity score method 
adjust only observed covariates and not for unobserved 
ones. This is always a limitation for non randomized studies 
compared to randomized studies or trails. Randomization 
tends to balance both  
(1)Observed covariates 
(2)Unobserved covariates 
Therefore, some sensitivity analysis for hidden bias is often 
desirable in a medical product regulatory submission based 
on non randomized study. It is very important that 
propensity score methods may not eliminate all the bias 
resulting from imbalance in observed covariates. Due to the 
limitation of propensity score modeling which typically uses 
a linear combination of covariates. 
 Braitman and Rosenbaum(6) States that Propensity 
score methods work under 3 conditions 
(1)When clinical outcome is rare 
(2)When there is large number of patients in each treatment 
group 
(3)When there are many covariates measured. 
In Regulatory setting it may be inappropriate to conduct 
propensity score analysis when the sample size is small. All 
observed covariates could be balanced between two 
treatment groups by propensity scores. It is essential to 
collect a baseline covariates and this is potentially related to  
(1)Treatment assignment 
(2)Clinical outcomes 
 Baseline covariates are well measured and used in data 
analysis. Rubin emphasizes importance of designing of 
observational studies.  
Applications:- 
 Matched sampling on univariate propensity score 
 Multivariate adjustment on propensity score 
 Visual representation of multivariate covariants by two 
dimensional plots. 
 Serves as a vehicle for equating non randomized 
groups on large number of measured baseline 
covariates and mimics the balance achieved by 
randomization on those covariates. 
Issues in propensity score approach:- 
When practically and theoretically propensity score 
approach is applied by the researcher then issues may occur. 
The main issue arising in the propensity score analysis is the 
space limitation that is very less space is permitted for these 
issues. 
Conclusion:- 
From  various observational studies, the practice of 
randomized controlled trials provide important information 
about various principles like principles of  pre specification, 
blinding, use of diagnostics etc. These methods also ensure 
the safety of various medical products. Propensity score 
models should be constructed only on the basis of 
knowledge of baseline covariates and treatment assigned. 
The main goal of propensity score is to create a balance in 
each of the two groups. 
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